EGFR expression in neurogenic tumors has been reported by several investigators, and the data showed that it is a very important receptor in neurofibromatosis 1, neurofibroma, and MPNST [11,19,27,28]. This evidence concerns the gene EGFR and neurofibromatosis type 1.